Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat

March 15, 2024

https://www.globenewswire.com/news-release/2024/03/15/2846998/0/en/Iterum-Therapeutics-to-Participate-in-H-C-Wainwright-Virtual-Home-Fireside-Chat.html

DUBLIN, Ireland and CHICAGO, March 15, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq:ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next-generation oral antibiotics to treat infections caused by multi-drug resistant pathogens in community settings, announced today that the company will participate in a virtual H.C. Wainwright @Home Fireside Chat on March 21, 2024. Corey Fishman, Iterum’s Chief Executive Officer, Sailaja Puttagunta, M.D., Iterum’s Chief Medical Officer, and Judy Matthews, Iterum’s Chief Financial Officer, will discuss Iterum’s lead program, oral sulopenem, for the treatment of adult women with uncomplicated urinary tract infections (uUTI).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.